S. Han

Allelic loss of the NF1 gene in anal malignant melanoma in a patient with neurofibromatosis type 1

A. Horii, H. Nagura, K. Shiiba, 2001, International Journal of Clinical Oncology.

The common −318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves’ patients

Shizhong Han, R. Li, S. Zhang, 2006, International journal of immunogenetics.

PP01.05 Impact of PD-L1 Status on Survival on Immunotherapy Monotherapy in Real-World Patients with Poor Performance Status: A US Nationwide Veterans Affairs Study

M. Brophy, N. Fillmore, N. Do, 2023, Journal of Thoracic Oncology.

738P Quality-adjusted time without symptom or toxicity (QA-TWiST) and quality-adjusted progression-free survival (QA-PFS) of first-line (1L) maintenance niraparib in patients with advanced ovarian cancer (OC): Results from the PRIMA trial

D. O’Malley, A. Redondo, D. Lorusso, 2021, Annals of Oncology.

17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial

K. Jardon, P. Follana, F. Heitz, 2020 .